Fontaine L Eveque

Human papillomavirus HPV infection is very common and often causes warts, which can appear at any age. This research investigates the effectiveness of two treatments, 2LVERU4 JUNIOR and 2LVERU4, compared to a placebo, in helping warts disappear. The study is placebo-controlled, randomized, and double-blind, aiming to see if these treatments improve wart clearance by the end of six months of treatment. Participants will take one capsule daily for six months, either 2LVERU4 JUNIOR or 2LVERU4, or a placebo, all taken on an empty stomach before breakfast. After the treatment phase, there is a three-month follow-up to monitor for any wart recurrence. Success is measured by normal skin color, texture, and touch at wart sites compared to the start of the study. During the study, participants will have regular assessments up to nine months from the start, including checking wart disappearance at four and six months and tracking any recurrence three months after treatment ends. Pain related to warts and safety through adverse event monitoring will also be evaluated. The study expects to enroll 162 patients aged three years and older with common, plantar, or flat warts.